Document is current
Any future updates will be listed below
-
Authors
Aparicio-Blanco, Juan
Vishwakarma, Nikhar
Lehr, Claus-Michael
Prestidge, Clive A.
Thomas, Nicky
Roberts, Richard J.
Thorn, Chelsea R.
Melero, Ana https://orcid.org/0000-0003-0126-414X
-
Funding
Funding for this research was provided by:
Universitat de Valencia
- License Information
-
More Information
Article History
Accepted: 23 December 2023
First Online: 10 February 2024
Declarations
:
: This study did not require ethics approval and did not involve human subjects.
: Not applicable.
: The authors have no relevant financial or non-financial interests to disclose. Chelsea Thorn is an employee of Pfizer Inc. and may have a financial interest in the company in the form of stock, stock options, and other forms of employment-related long-term incentives.
: This perspective manuscript is part of thematic articles that belong to a collaboration between the Young Scientists Committee of the Controlled Release Society and Drug Delivery and Translational Research and is organized and edited by Dr. Tushar Kumeria and Dr. Hagar Labouta as DDTR Young Associate editors.
